These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37077068)

  • 1. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
    Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
    Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
    Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
    J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
    Choi JH; Ro JY
    Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
    Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
    Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of adrenal ganglioneuroblastoma-intermixed in an adult and a review of literature.
    Vassallo L; Fasciano M; Baralis I; Pellegrino L; Fortunato M; Orcioni GF; Sorrentino S
    Radiol Case Rep; 2021 Sep; 16(9):2351-2356. PubMed ID: 34306280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
    Warren M; Matsuno R; Tran H; Shimada H
    Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 16. A Metastatic Neuroblastic Tumor in a 28-Month-old Boy: Unusual Spontaneous Regression From Neuroblastoma to Ganglioneuroma?
    Yamada A; Kinoshita M; Kamimura S; Nakame K; Moritake H
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e589-e592. PubMed ID: 34054050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
    Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
    Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peripheral neuroblastic tumors in childhood].
    Bernhardt M; Vokuhl C
    Pathologie (Heidelb); 2023 Nov; 44(6):366-372. PubMed ID: 37819531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.